|
Volumn 13, Issue 7 SUPPL., 1999, Pages 96-97
|
Uracil/tegafur plus oral calcium folinate in advanced breast cancer
a,b b c c c c c c c c c c c c c |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOGLUTETHIMIDE;
ANTHRACYCLINE;
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
FLUOROURACIL;
FOLINATE CALCIUM;
METHOTREXATE;
MITOMYCIN C;
MITOXANTRONE;
NAVELBINE;
ORZEL;
PACLITAXEL;
TAMOXIFEN;
TAMOXIFEN CITRATE;
UFT;
UNCLASSIFIED DRUG;
URACIL;
ABDOMINAL PAIN;
ADULT;
ADVANCED CANCER;
AGED;
ANTINEOPLASTIC ACTIVITY;
BREAST CANCER;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
DRUG TOLERABILITY;
FATIGUE;
HUMAN;
LEUKOPENIA;
MUCOSA INFLAMMATION;
NAUSEA;
ORAL DRUG ADMINISTRATION;
PHASE 2 CLINICAL TRIAL;
|
EID: 6544232849
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (5)
|
References (8)
|